Skip to main content
logo
ImmunityBio, Inc. (IBRX)
NASDAQ: IBRX · Real-Time Price · USD
2.020
+0.040 (2.02%)
At close: Jan 2, 2026, 4:00 PM EST
2.050
+0.030 (1.49%)
After-hours: Jan 2, 2026, 7:57 PM EST

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
United States Revenue
-14.21M
Log In
Log In
Log In
Upgrade
Europe Revenue
-531.00K
Log In
Log In
Log In
Upgrade
Revenue (Total)
82.56M14.75M
Log In
Log In
Log In
Upgrade

Revenue

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2024FY 2023FY 2022FY 20212018 - 2020
Period Ending
Sep '25 Dec '24 Dec '23 Dec '22 Dec '21 2018 - 2020
Product Revenue
81.92M14.15M
Log In
Log In
Log In
Upgrade
Other Revenue
639.00K595.00K
Log In
Log In
Log In
Upgrade
Revenue (Total)
82.56M14.75M
Log In
Log In
Log In
Upgrade
Updated Sep 30, 2025. Data Source: Fiscal.ai.